Pacer Advisors
CORT icon

Pacer Advisors’s Corcept Therapeutics CORT Stock Holding History

Pacer Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$232K Sell
2,673
-511
-16% -$30.9K ﹤0.01% 1744
2026
Q1 		$128K Buy
3,184
+1,154
+57% +$43.2K ﹤0.01% 1808
2025
Q4 		$70.6K Sell
2,030
-388,529
-99% -$30.5M ﹤0.01% 3207
2025
Q3 		$32.5M Buy
390,559
+384,896
+6,797% +$27.9M 0.08% 232
2025
Q2 		$416K Sell
5,663
-5,237
-48% -$380K ﹤0.01% 1473
2025
Q1 		$1.24M Buy
10,900
+4
+0% +$243 ﹤0.01% 1119
2024
Q4 		$549K Buy
10,896
+1,689
+18% +$88.5K ﹤0.01% 1586
2024
Q3 		$426K Buy
9,207
+5,355
+139% +$190K ﹤0.01% 1687
2024
Q2 		$125K Buy
3,852
+2,728
+243% +$74.7K ﹤0.01% 2134
2024
Q1 		$28.3K Sell
1,124
-173
-13% -$4.09K ﹤0.01% 3371
2023
Q4 		$42.1K Sell
1,297
-118
-8% -$3.24K ﹤0.01% 3162
2023
Q3 		$38.6K Buy
1,415
+754
+114% +$21.8K ﹤0.01% 2496
2023
Q2 		$14.7K Sell
661
-518,895
-100% -$11.9M ﹤0.01% 3337
2023
Q1 		$11.3M Buy
519,556
+61,087
+13% +$1.34M 0.05% 364
2022
Q4 		$9.31M Buy
458,469
+148,864
+48% +$3.73M 0.05% 357
2022
Q3 		$7.94M Sell
309,605
-53,698
-15% -$1.44M 0.06% 291
2022
Q2 		$8.64M Buy
363,303
+102,693
+39% +$2.24M 0.06% 263
2022
Q1 		$5.87M Buy
260,610
+11,350
+5% +$241K 0.05% 394
2021
Q4 		$4.93M Buy
+249,260
New +$5.06M 0.05% 445
2020
Q4 		– Sell
-18,327
Closed -$319K – 1510
2020
Q3 		$319K Buy
18,327
+2,202
+14% +$35.1K 0.01% 1113
2020
Q2 		$271K Buy
16,125
+1,058
+7% +$14.9K 0.01% 790
2020
Q1 		$190K Sell
15,067
-14,709
-49% -$182K ﹤0.01% 429
2019
Q4 		$360K Sell
29,776
-5,493
-16% -$76.5K 0.02% 857
2019
Q3 		$499K Sell
35,269
-3,368
-9% -$41.4K 0.01% 987
2019
Q2 		$431K Sell
38,637
-986
-2% -$11K 0.01% 996
2019
Q1 		$465K Buy
39,623
+15,238
+62% +$189K 0.01% 589
2018
Q4 		$326K Buy
24,385
+10,666
+78% +$141K 0.01% 177
2018
Q3 		$192K Buy
+13,719
New +$192K 0.01% 1035

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pacer Advisors's CORT Position: Q2 2026 in Review

Pacer Advisors reduced its Corcept Therapeutics (CORT) stake by 16% in Q2 2026, selling an estimated $30.9K and leaving 2,673 shares worth $232K. The position accounts for ﹤0.01% of the portfolio, ranked #1744.

Pacer Advisors first reported a position in CORT in Q3 2018 and has held it in 28 quarters since. The position peaked at $32.5M in Q3 2025. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Pacer Advisors held 2,673 shares of Corcept Therapeutics worth $232K as of Q2 2026.
  • Pacer Advisors sold 511 Corcept Therapeutics shares in Q2 2026, an estimated $30.9K.
  • Corcept Therapeutics made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #1744 holding.
  • Pacer Advisors first reported a position in Corcept Therapeutics in Q3 2018 and has held it in 28 quarters since.
  • Pacer Advisors's Corcept Therapeutics position peaked at $32.5M in Q3 2025.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.